S. Iwasa et al., Blockade of endothelin receptors reduces diet-induced hypercholesterolemiaand atherosclerosis in apolipoprotein E-deficient mice, PATHOBIOLOG, 69(1), 2001, pp. 1-10
Objective: Endothelin (ET)-1 has proatherogenic properties, since ET recept
or antagonists reduce atherosclerotic lesions in animals. However, we recen
tly demonstrated that ET-1 and ETB receptors are increased in atherosclerot
ic lesions. To further examine the effects of ETB receptor antagonism on at
herogenesis, we investigated the chronic effects of the nonselective ETA/ET
B receptor antagonist SB209670 on the development of atherosclerosis in apo
lipoprotein E (ApoE)-deficient mice.
Methods: Ninety-four male mice (10 weeks of age) were randomly divided into
four groups: mice fed a Western-type diet or a chow diet with SB209670 tre
atment (10 mg/kg/day) or placebo for 12 weeks.
Results: In mice fed the Western-type diet, but not in mice fed the chow di
et, treatment with SB209670 significantly attenuated the increase in plasma
total cholesterol, predominantly in the very-low-density lipoprotein and i
ntermediate-density lipoprotein fractions, without altering the plasma trig
lyceride level. Furthermore, treatment with SB209670 significantly reduced
the extent of aortic atherosclerosis, by 53% in mice fed the Western-type d
iet and by 38% in mice fed the chow diet. Histological analysis revealed th
at SB209670 prevented the formation of atheromatous plaque lesions by inhib
iting the fibroproliferative process.
Conclusion: We found that chronic administration of SB209670 reduced diet-i
nduced hypercholesterolemia and atherosclerosis in ApoE-deficient mice. Thu
s, nonselective ET receptor antagonists may have a therapeutic potential in
the treatment of human atherosclerotic disease. Copyright (C) 2001 S. Karg
er AG, Basel.